NAMI
Jinxin Technology·NASDAQ
--
--(--)
--
--(--)
0.53 / 10
Underperform
The fundamental analysis reveals poor quality with a 0.5/10 score. Key concerns include an Asset-liability ratio of 37.67% (group 1, negative historical returns), a Current ratio of 1.67 (group 3, neutral), and an Equity ratio of 0.77 (group 1, negative). Only the Interest coverage ratio of 27.60 (group 2) provides a mildly positive signal, but it is insufficient to offset other weaknesses.
Analysis Checks(1/5)
Asset-liability ratio (%)
Value37.67
Score0/3
Weight38.12%
1M Return-2.44%
Value37.67
Score0/3
Weight38.12%
1M Return-2.44%
Long-term debt to working capital ratio (%)
Value0.06
Score0/3
Weight46.32%
1M Return-3.20%
Value0.06
Score0/3
Weight46.32%
1M Return-3.20%
Current ratio
Value1.67
Score1/3
Weight4.98%
1M Return-0.29%
Value1.67
Score1/3
Weight4.98%
1M Return-0.29%
Equity ratio (Total liabilities / Shareholders’ equity attributable to parent company) (%)
Value0.77
Score0/3
Weight37.93%
1M Return-2.36%
Value0.77
Score0/3
Weight37.93%
1M Return-2.36%
Interest coverage ratio (EBIT / Interest expense) (%)
Value27.60
Score2/3
Weight-27.35%
1M Return1.53%
Value27.60
Score2/3
Weight-27.35%
1M Return1.53%
Asset-liability ratio (%)
Value37.67
Score0/3
Weight38.12%
1M Return-2.44%
Value37.67
Score0/3
Weight38.12%
1M Return-2.44%
Equity ratio (Total liabilities / Shareholders’ equity attributable to parent company) (%)
Value0.77
Score0/3
Weight37.93%
1M Return-2.36%
Value0.77
Score0/3
Weight37.93%
1M Return-2.36%
Long-term debt to working capital ratio (%)
Value0.06
Score0/3
Weight46.32%
1M Return-3.20%
Value0.06
Score0/3
Weight46.32%
1M Return-3.20%
Interest coverage ratio (EBIT / Interest expense) (%)
Value27.60
Score2/3
Weight-27.35%
1M Return1.53%
Value27.60
Score2/3
Weight-27.35%
1M Return1.53%
Current ratio
Value1.67
Score1/3
Weight4.98%
1M Return-0.29%
Value1.67
Score1/3
Weight4.98%
1M Return-0.29%
Is NAMI undervalued or overvalued?
- NAMI scores 0.53/10 on fundamentals and holds a Premium valuation at present. Backed by its -13.48% ROE, -5.86% net margin, -12.29 P/E ratio, 2.23 P/B ratio, and 0.00% earnings growth, these metrics solidify its Underperform investment rating.
